Literature DB >> 26614551

Use of complementary and alternative medicine (CAM) by parents in their children and adolescents with epilepsy - Prevelance, predictors and parents' assessment.

Nicole Hartmann1, Martina P Neininger2, Matthias K Bernhard1, Steffen Syrbe1, Petra Nickel1, Andreas Merkenschlager1, Wieland Kiess1, Thilo Bertsche2, Astrid Bertsche3.   

Abstract

BACKGROUND: The use of complementary and alternative medicine (CAM) is popular. Parents of children suffering from epilepsy may also consider administering CAM to their children. Systematic data about frequency of and motivations for CAM use, however, are scarce.
METHODS: In a university hospital's neuropaediatric department parents of patients aged 0-18 years suffering from epilepsy were consecutively invited to take part in a structured interview during 4 months in 2014.
RESULTS: Of the invited parents, 164/165 (99%) agreed to participate. From those, 21/164 (13%) stated that they used CAM in their child. The highest independent predictive value of CAM use was the occurrence of adverse drug events (ADE) of anticonvulsants as judged by parents. Patients affected by ADE had a 5.6 higher chance of receiving CAM compared to patients without ADE. Most commonly used were homeopathy (14/21, 67%) and osteopathy (12/21, 57%). The internet was the most frequently used source of information (14/21, 67%). Of the parents, 10/21 (48%) described positive effects of CAM on seizure frequency, 12/21 (57%) on general condition of their child, and 20/21 (95%) wished to continue CAM for epilepsy therapy. From the non-users of CAM, 91/143 (66%) expressed the desire to learn more about CAM for epilepsy therapy. LIMITATIONS: Our study was performed in a university hospital in a large urban city in Eastern Germany. CAM user rates can differ in other parts of Germany and Europe, in other institutions and for chronic diseases other than epilepsy.
CONCLUSION: The main reason for CAM use was the occurrence of ADE of anticonvulsants. More than half of the parents saw a benefit of CAM for their children. Almost all parents wished to continue CAM use, even those who did not see concrete positive effects.
Copyright © 2015 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Children; Complementary and alternative medicine (CAM); Epilepsy; Homeopathy; Osteopathy

Mesh:

Substances:

Year:  2015        PMID: 26614551     DOI: 10.1016/j.ejpn.2015.11.003

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  7 in total

1.  Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations.

Authors:  Jesse Elliott; Sasha van Katwyk; Bláthnaid McCoy; Tammy Clifford; Beth K Potter; Becky Skidmore; George A Wells; Doug Coyle
Journal:  Pharmacoeconomics       Date:  2019-10       Impact factor: 4.981

2.  Complementary and alternative medicine experiences of mothers in the treatment of infantile colic.

Authors:  Ayse Oflu; Aysegul Bukulmez; Oya Gorel; Busegul Acar; Yusuf Can; Nihat Cem Ilgaz; Ibrahim Yenioglu; Serkan Uygun; Sultan Sulecik
Journal:  Sudan J Paediatr       Date:  2020

3.  Predictors for the use of herbal and dietary supplements in children and adolescents with kidney and urinary tract diseases.

Authors:  Tugba Tastemel Ozturk; Nuray Kanbur; Elif Nursel Ozmert; Bora Gulhan; Fatih Ozaltin; Rezan Topaloglu; Ali Duzova
Journal:  Eur J Pediatr       Date:  2020-08-06       Impact factor: 3.183

4.  Experiences, expectations, and fears of adolescents with epilepsy or bronchial asthma.

Authors:  Susanne Marie Fisch; Martina Patrizia Neininger; Freerk Prenzel; Matthias Karl Bernhard; Frauke Hornemann; Andreas Merkenschlager; Wieland Kiess; Thilo Bertsche; Astrid Bertsche
Journal:  Eur J Pediatr       Date:  2018-07-03       Impact factor: 3.183

Review 5.  The chiropractic profession: a scoping review of utilization rates, reasons for seeking care, patient profiles, and care provided.

Authors:  Peter J H Beliveau; Jessica J Wong; Deborah A Sutton; Nir Ben Simon; André E Bussières; Silvano A Mior; Simon D French
Journal:  Chiropr Man Therap       Date:  2017-11-22

6.  Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations.

Authors:  Jesse Elliott; Bláthnaid McCoy; Tammy Clifford; Beth K Potter; Becky Skidmore; George A Wells; Doug Coyle
Journal:  Syst Rev       Date:  2019-03-27

7.  Physicians' perspectives on adverse drug reactions in pediatric routine care: a survey.

Authors:  Martina P Neininger; Sarah Jeschke; Lisa M Kiesel; Thilo Bertsche; Astrid Bertsche
Journal:  World J Pediatr       Date:  2021-11-13       Impact factor: 2.764

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.